Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1786)
  2. Journal Article (1579)
  3. Review (119)
  4. Research Letter (54)
  5. Editorial (46)
  6. Book Section (39)
  7. Guidelines (19)
  8. Conference Paper (18)
  9. Correspondence (12)
  10. Miscellaneous (2)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3675)
  2. Department of Medicine (3644)
  3. Hematologic Malignancies, Division of (3640)
  4. GSK Faculty (1773)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1369)
  6. Executive Committee, Center for Hematologic Malignancies (965)

More Groups

People
  1. Ross Levine (782)
  2. Martin Tallman (651)
  3. David Scheinberg (499)
  4. Jae Park (370)
  5. Eytan Stein (361)
  6. Raajit Rampal (347)

More People

Years
  1. 2025 (61)
  2. 2024 (193)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1249)
  2. Journal of Clinical Oncology (215)
  3. Clinical Lymphoma, Myeloma and Leukemia (116)
  4. Leukemia (109)
  5. Haematologica (106)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1338)
  2. Nature Publishing Group (319)
  3. Elsevier Inc. (256)
  4. American Association for Cancer Research (233)
  5. American Society of Clinical Oncology (227)
  6. Ferrata Storti Foundation (106)

More Publishers

Results (3675)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outpatient vs inpatient HiDA consolidation for AML: The MSKCC experience
    Meeting Abstract

    Boussi, L.; Burton, H.; Derkach, A.; Nemirovsky, D.; Ciervo, J.; Tallman, M. S.; Stein, E. M.; Cai, S.
    Blood (2024)

    Fulltext@MSK | Save
  • Development of CAR T cells targeting U5 snRNP200 for the treatment of acute myeloid and B-lymphoid leukemias
    Meeting Abstract

    Fujino, T.; Lewis, J.; Chen, B. Y.; Sievers, Q.; Cai, W.; Yoo, S.; Mathew, S.; Souness, S.; Burns, E. R.; Um, J. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Mis-splicing derived neoantigens and cognate T cell receptors in splicing factor mutant myeloid neoplasms
    Meeting Abstract

    Kim, W. J.; Crosse, E. I.; De Neef, E.; Etxeberria, I.; Sabio, E.; Wang, E.; Bewersdorf, J. P.; Lu, S. X.; Belleville, A.; Fox, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Non-driver genomic alterations and venous thromboembolism in myeloproliferative neoplasms
    Meeting Abstract

    Ajufo, H.; Leader, A.; Derkach, A.; Chrysafi, P.; Singh, R.; Rampal, R.; Mantha, S.; Zwicker, J. I.
    Blood (2024)

    Fulltext@MSK | Save
  • TMPRSS6 antisense oligonucleotide therapy reverses inflammation in Jak2(V617F) mutant mice
    Meeting Abstract

    Levy, M.; Li, H.; Dunbar, A.; Huang, Z.; Park, Y.; Lu, M.; Phattalung, P. N.; Planoutene, M.; Casu, C.; Rivella, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Assessing role of comorbidities in treatment selection for older patients with acute myeloid leukemia
    Meeting Abstract

    Grenet, J.; Easwar, N.; Jain, A. G.; Burkart, M.; Ma, X.; Christos, P.; Ritchie, E. K.; Samuel, M.; Kaner, J. D.; Canaani, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Transcriptomic and epigenomic landscape of hairy cell leukemia at single-cell resolution
    Meeting Abstract

    Eton, E. O.; Ganesan, S.; Murray, R. M.; Durham, B. H.; Park, J. H.; Abdel-Wahab, O.; Landau, D. A.
    Blood (2024)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose escalation and dose expansion, multicenter clinical trial to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of lomonitinib (ZE46-0134) in adults with FLT3-mutated relapsed or refractory acute myeloid leukemia
    Meeting Abstract

    Lin, T. L.; Koenig, K. L.; Swords, R. T.; Stein, E. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; Olin, R.; Blum, W.; Schiller, G. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Hematologic improvement experienced by pacritinib-treated patients with myelofibrosis in real-world clinical settings
    Meeting Abstract

    Marrone, M.; Morere, L.; Oladapo, A.; Suthar, P.; Sura, T.; Vasudevan, A.; Vredenburg, M.; Zeng, J.; Rampal, R.; Mascarenhas, J. O.
    Blood (2024)

    Fulltext@MSK | Save
  • A randomized phase 2 trial of 28-day (Arm A) versus 14-day (Arm B) schedule of venetoclax + azacitidine in newly diagnosed acute myeloid leukemia patients ≥ 60 years
    Meeting Abstract

    Borate, U.; Huang, Y.; Zeidner, J. F.; Swords, R. T.; Koenig, K. L.; Stein, E. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; Olin, R.; more...
    Blood (2024)

    Fulltext@MSK | Save